Related Experiment Videos
Radiopharmaceutical-related pitfalls and artifacts
J C Hung1, J A Ponto, R J Hammes
1Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Seminars in Nuclear Medicine
|October 1, 1996
Summary
This review details common radiopharmaceutical preparation and administration issues, offering insights into their causes and prevention strategies for improved nuclear medicine imaging. Understanding these pitfalls enhances diagnostic accuracy.
Area of Science:
- Nuclear Medicine
- Radiopharmacy
- Medical Imaging
Background:
- Radiopharmaceuticals are crucial in nuclear medicine for diagnosis and therapy.
- Commonly used radiopharmaceuticals can present challenges in preparation and administration.
- Understanding these challenges is vital for accurate diagnostic imaging.
Purpose of the Study:
- To comprehensively review and elucidate problems associated with radiopharmaceuticals in clinical practice.
- To categorize and explain pitfalls and artifacts in radiopharmaceutical preparation and administration.
- To provide insights into causative factors and preventive measures for radiopharmaceutical-related issues.
Main Methods:
- Literature-based review of radiopharmaceutical preparation and administration problems.
- Categorization of issues into formulation-associated (radionuclide, component, procedure factors) and administration-associated (technique, nontechnical errors) pitfalls.
- Presentation of clinical manifestations and causative factors with preventive actions.
Main Results:
- Identified common pitfalls in radiopharmaceutical preparation, including technetium-99m ([99mTc])-labeled and non-[99mTc]-labeled agents.
- Detailed errors in radiopharmaceutical administration techniques and nontechnical aspects.
- Provided examples of clinical manifestations and discussed the impact of various causative factors.
Conclusions:
- Recognizing and addressing radiopharmaceutical preparation and administration pitfalls is essential for optimizing nuclear medicine procedures.
- While many issues have identifiable causes and preventive strategies, some problems remain challenging to diagnose and manage.
- Further research may be needed to fully understand and mitigate all radiopharmaceutical-related challenges.